ÐÕÃû:ºî°²¼Ì Ö÷ÈÎҽʦ¡¢Ò½Ñ§²©Ê¿
Ö°Îñ:3BÖ×Áö¿ÆÖ÷ÈÎ
ºî°²¼Ì£¬ÄУ¬Ö÷ÈÎҽʦ£¬Ò½Ñ§²©Ê¿£¬Öй²µ³Ô±¡£1984Äê±¾¿Æ±ÏÒµÓÚºþ±±ÖÐҽѧԺ£¬1991Äê˶ʿÑо¿Éú±ÏÒµÓÚͬ¼ÃÒ½¿Æ´óѧ£¬2007Ä격ʿ±ÏÒµÓÚÎ人´óѧҽѧԺ¡£Ôø»ñ¿Æ¼¼²¿Õñ»ª¿Æ¼¼·öƶ½±Àø»ù½ð·þÎñ½±µÈ¡£Ôø±»Æ¸Îªºþ±±ÖÐÒ½Ò©´óѧ¼æÖ°½ÌÊÚ¡¢ÄþÏÄÒ½¿Æ´óѧÖ×Áöѧרҵ˶ʿÑо¿ÉúÖ¸µ¼½Ìʦ¡£ÏȺóÔÚÎ人´óѧÖÐÄÏÒ½Ôº(Èý¼×)¡¢ÉϺ£ÖÐÒ½Ò©´óѧ¸½ÊôµÚÆßÈËÃñÒ½Ôº(Èý¼×)¡¢¸´µ©´óѧ¸½ÊôÐì»ãÒ½Ôº(Èý¼¶)µÈÒ½Ôº¹¤×÷£¬ÔøÈÎÖ×Áö¿Æ¼°Ö×ÁöÄÚ¿Æ¿ÆÖ÷ÈΡ£
´ÓÊÂÖÐÎ÷Ò½½áºÏÁÙ´²Óë¿ÆÑй¤×÷40Ä꣬ÔÚʵÌåÖ×Áö»¯ÁƺÍÖÐÒ½ÖÎÁÆ·½ÃæÓзḻ¾Ñ飬Éó¤Ö×Áö»¯ÁÆ¡¢°ÐÏòºÍÃâÒßÖÎÁÆ£¬¼°ÖÐÒ½ÖÎÁÆÖ×ÁöºÍÄÚ¿ÆÔÓ²¡£¬¶Ô·ÇСϸ°û·Î°©¡¢Ê³¹Ü°©¡¢Î¸°©¡¢¸Î°©¡¢½áÖ±³¦°©µÈµÄÖÐÎ÷Ò½½áºÏÖÎÁÆÓнÏÉîÔìÒè¡£ÏȺ󷢱íÂÛÖø40ÓàÆª(SCI6ƪ)£¬³Ðµ£¿ÎÌâ10ÓàÏ»ñÊ¡¼¶¿Æ¼¼½±Àø4´Î¡£
ÔÚʵÌåÖ×Áö»¯ÁƺÍÖÐÒ½ÖÎÁÆ·½ÃæÓзḻ¾Ñ飬Éó¤Ö×Áö»¯ÁÆ¡¢°ÐÏòºÍÃâÒßÖÎÁÆ£¬¼°ÖÐÒ½ÖÎÁÆÖ×ÁöºÍÄÚ¿ÆÔÓ²¡£¬¶Ô·ÇСϸ°û·Î°©¡¢Ê³¹Ü°©¡¢Î¸°©¡¢¸Î°©¡¢½áÖ±³¦°©µÈµÄÖÐÎ÷Ò½½áºÏÖÎÁÆÓнÏÉîÔìÒè¡£
ÔÚ¿ÆÑз½ÃæË¶¹ûÀÛÀÛ£¬ÏȺ󷢱íÂÛÖø40ÓàÆª(SCI6ƪ)£¬³Ðµ£¿ÎÌâ10ÓàÏ»ñÊ¡¼¶¿Æ¼¼½±Àø4´Î¡£
Ò»¡¢»ñ½±Çé¿ö£º
1.1998Ä꣬¡¶Èȶ¾Çå×¢ÉäÒº¿¹ÄÚ¶¾ËØÓйػúÀíµÄÑо¿¡·»ñºþ±±Ê¡ÈËÃñÕþ¸®¿Æ¼¼½ø²½¶þµÈ½±¡£
2.1999Ä꣬¡¶¸üÄêÆ½µ÷Òº¶Ô¸üÄêÆÚ´óÊóÐ£»¤×÷ÓõÄʵÑéÑо¿¡·»ñºþ±±Ê¡ÈËÃñÕþ¸®¿Æ¼¼½ø²½ÈýµÈ½±¡£
3.2003Ä꣬¡¶¼¸ÖÖ²¹ÉöÖÐÒ©ÑÓ»ºË¥ÀϵÄʵÑéÓëÁÙ´²Ñо¿¡·»ñºþ±±Ê¡ÈËÃñÕþ¸®¿Æ¼¼½ø²½ÈýµÈ½±¡£
4.2004Ä꣬¡¶¼¸ÖÖ²¹ÉöÖÐÒ©ÓëÀûά°®ÑÓ»ºÀÏÄê´ÆÐÔ´óÊóË¥ÀϵÄʵÑéÑо¿¡·»ñÎ人ÊÐÈËÃñÕþ¸®¿Æ¼¼½ø²½ÈýµÈ½±¡£
¶þ¡¢¿ÎÌâÑо¿£º
1.¡¶ÖÐÒ½Ö×Áö²¡Ñ§¡·Öصãѧ¿Æ½¨ÉèÏîÄ¿£¬±àºÅ£ºZYXK2012010£¬ÉϺ£ÊÐÎÀÉú¾Ö¡¢Öз¢°ì¡£
2.¡¶ÖÐÒ½×ÛºÏÖÎÁÆÍíÆÚ·ÇСϸ°û·Î°©µÄ·½°¸¼°ÍƹãÓ¦ÓÃÑо¿¡·±àºÅ£º201107003
¹ú¼Ò863ÏîÄ¿×Ó¿ÎÌâ¡£
2.¡¶ÁöÄÚÃâÒß°ÐÏò·ÅÁÆÁªºÏ΢²¨ÏûÈÚ¼¼ÊõÖÎÁƷΰ©µÄÁÙ´²Ñо¿¡·±àºÅ£ºW2011BX118£¬ÎÀÉú²¿Ò½Ò©ÎÀÉú¿Æ¼¼·¢Õ¹Ñо¿ÖÐÐÄ¡£
3.¡¶Ñª¹Ü½ôÕÅËØ×ª»»Ã¸»ùÒò¶à̬ÐÔÓë´ó³¦°©ÁÙ´²ÌØÕ÷Ñо¿¡·±àºÅ£º2011419ÉϺ£ÊÐÎÀÉú¾ÖÃæÉÏÏîÄ¿¡£
4.¡¶ÊæÑªÄþ×¢ÉäÒºµÈÒ©Æ·µÄ°²È«ÐÔÆÀ¼Û(×Ó¿ÎÌâ)¡·±àºÅ£º12DZ1930604£¬ÉϺ£ÊпÆÎ¯¡£
5.¡¶Þ°¬»Ó·¢Ó͵ÄÌáÈ¡¼°Ò©Ð§Ñ§Ñо¿¡·ºþ±±Ê¡½ÌÓýÌü¡£
6.¡¶ôȼ׻ùÜòÜß¶àÌÇ¿¹´óÊó¸ÎÏËά»¯×÷ÓõÄʵÑéÑо¿¡·ºþ±±Ê¡ÎÀÉúÌü¡£
7.¡¶ÜòÜß¶àÌǶÔѼÒÒ¸ÎÄ£ÐÍÍâÖÜѪÊ÷ͻ״ϸ°ûÓ°ÏìµÄʵÑéÑо¿¡·ºþ±±Ê¡×ÔÈ»»ù½ð¡£
8.¡¶Èȶ¾ÇåÞ׿¹ÄÚ¶¾ËØ»úÀíµÄϵÁÐÑо¿¡·¹ú¼ÒÆßÎå¹¥¹Ø¼Æ»®ÏîÄ¿¡£
9.¡¶¸üÄêÆ½µ÷ÒºÖÎÁƸüÄêÆÚ×ÛºÏÕ÷µÄÁÙ´²ÓëʵÑéÑо¿¡·ºþ±±Ê¡ÎÀÉúÌü¡£
10.¡¶¸üÄêÆÚ×ÛºÏÕ÷¸ÎÑôÉÏ¿ºÖ¤¸ÎÓôÆøÖÍÖ¤ºê¹ÛÓë΢¹Û±æÖ¤Ñо¿¡·ºþ±±Ê¡ÎÀÉúÌü¡£
11.¡¶¸üÄêÆ½µ÷Òº¶Ô¸üÄêÆÚ´óÊóÐ£»¤×÷ÓõÄʵÑéÑо¿¡· ºþ±±Ê¡ÎÀÉúÌü ¡£
12.¡¶ÐÂÒ©¸üÄêÆ½µ÷ÒºµÄÑÐÖÆ¡·ºþ±±Ê¡¿Æ¼¼Ìü¡£
13.¡¶³¦°©»¼ÕßÍâÖÜѪACE»ùÒò¶à̬ÐÔ·ÖÎö¡·ÉϺ£ÊÐÆÖ¶«ÐÂÇøÉç·¢¾Ö¡£
14.¡¶ÀÏÄê·ÇСϸ°û·Î°©»¼ÕßÍâÖÜѪÊ÷ͻ״ϸ°ûÓëÔ¤ºó¹ØÏµµÄÁÙ´²Ñо¿¡·ÉϺ£ÊÐÆÖ¶«ÐÂÇø¿ÆÎ¯¿Æ¼¼¹¥¹ØÏîÄ¿¡£
Èý¡¢²¿·Ö·¢±íÂÛÎÄ£º(º¬µÚÒ»×÷Õß¡¢Í¨Ñ¶×÷Õß)
1.Fuzheng Xiaoai Decoction 1 ameliorated cancer cachexia-induced muscle atrophy via Akt-mTOR pathwa.JournalofEthnopharmacology, 303(2023), 115944.
2.Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol, Medicine, 2020.
3.Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials. BMC Public Health£¬2014,14(204).
4.Folate intake and risk of breast cancer: a dose-response meta-analysis of prospective studies. Plos One.Accept.
5.Polyunsaturated fatty acid intake and risk of lung cancer: A meta-analysis of prospective studies. Am J Clin. Accept.
6.ÇåÈȽⶾÖÐÒ©ÁªºÏ»¯ÁƶÔÍíÆÚ·ÇСϸ°û·Î°©µÄÁÙ´²Ñо¿.ÁÉÄþÖÐÒ½ÔÓÖ¾£¬2012,39(2)£º303-305.
7.Ïû°©IºÅ·½ÁªºÏOFL·½°¸ÖÎÁÆÖÐÍíÆÚθ°©µÄÁÙ´²¹Û²ì.ÐÂÖÐÒ½£¬2011£¬43(2)£º104-106.
8.ÒæÆøÑøÒõÖÐÒ©¶ÔGP·½°¸»¯ÁÆÍíÆÚ·ÇСϸ°û·Î°©×÷ÓÃÁÙ´²Ñо¿.ÐÂÖÐÒ½£¬2011£¬43(9)£º47-49.
9.Ê÷ͻ״ϸ°û¹¦ÄÜÓëÀÏÄê·ÇСϸ°û·Î°©»¼ÕßÔ¤ºó¹ØÏµÑо¿.Î人´óѧѧ±¨(ҽѧ°æ)2010£¬31(6): 796-799.
10.½á³¦°©»¼ÕßÍâÖÜѪѪ¹Ü½ôÕÅËØ×ª»»Ã¸»ùÒò¶à̬ÐÔ.Ö×Áö·ÀÖÎÑо¿£¬2010£¬37(9)£º1040-1043.
11.Shenfu injection plus vinorelbine for elderly patients with non-small cell lung cancer in promoting the quality of life: a randomiced controlled clinical trial. Chinese-German Journal of Clinical Oncology, 2010£¬9(1)£º22-25.
12.½á³¦°©»¼ÕßÖ×Áö×éÖ¯ÖÐѪ¹Ü½ôÕÅËØ×ª»»Ã¸»ùÒò¶à̬ÐÔÑо¿.Ö×Áö£¬2010£¬30(3)£º265-266.
13.Weekly Docetaxel, Cisplatin and low dose Fluorouracil on Advanced Gastric Carcinoma: A Randomized Clinical Trial. Chinese-German Journal of Clinical Oncol., 2009, 9(9): 45-51.
14.ÖܼÁÁ¿¶àÎ÷×Ïɼ´¼¡¢Ë³²¬ÁªºÏµÍ¼ÁÁ¿·úÄòà×à¤ÖÎÁÆÍíÆÚθ°©µÄËæ»ú¶ÔÕÕÑо¿. Ö×Áö£¬2009£¬29(2)£º160-163.
15.·öÕýÏû°©¢ñºÅ·½ÖÎÁÆÍíÆÚ½áÖ±³¦°©ÁÆÐ§¹Û²ì.ʱÕä¹úÒ½¹úÒ©£¬2009£¬20(11)£º2908-2910.
16.²ÎÂó×¢ÉäÒºÁªºÏ¼ªÎ÷Ëû±õÌá¸ßÀÏÄê·ÇСϸ°û·Î°©Éú»îÖÊÁ¿µÄËæ»ú¶ÔÕÕÑо¿. ÉϺ£ÖÐÒ½Ò©ÔÓÖ¾£¬2009,43(9)£º24-26.
17.ÀÏÄêÒÖÓô´óÊóº£ÂíCA3ÇøC-fosºÍCaspase-3µ°°×µÄ±í´ï.Î人´óѧѧ±¨£¬2008£¬29(1)£º44-47.
18.²Î¸½×¢ÉäÒºÁªºÏ³¤´ºÈð±öÌá¸ßÀÏÄê·ÇСϸ°û·Î°©Éú»îÖÊÁ¿µÄËæ»ú¶ÔÕÕÑо¿.Öйú°©Ö¢ÔÓÖ¾£¬2008£¬18(6)£º446-449.
19.Carboxymethytl Pachymaram Up-Regulates Dendritic Cell‘s Function in Hepatitis B Virus Transgenic Mice. Front. Biol.China, 2008,3(4)£º408-413.
20.Carboxymethytl Pachymaram Up-Regulates Dendritic Cell‘s Function in Hepatitis B Virus Transgenic Mice in vitro¡£Wuhan Univ J.Nat Sci. , 2008,12(2): 372-378.
21.¶Ì²¨·øÉä¶ÔHBVת»ùÒòСÊóÊ÷ͻ״ϸ°û×÷ÓÃ.ÖлªÎïÀíҽѧÓ뿵¸´ÔÓÖ¾£¬2006,28(3)£º162-165.
22.Lishizhen herb wine’s effect on the weight of immune organs and lymphocyte blastogenesis in mouse.ÖйúÁÙ´²¿µ¸´ÔÓÖ¾(Ó¢Îİæ)2005£¬1.
23.·öÕýÏû°©¢ñºÅ·½ÖÎÁÆÖÐÍíÆÚÉÏÏû»¯µÀ¶ñÐÔÖ×ÁöµÄÁÙ´²Ñо¿.ÖйúÖÐÎ÷Ò½½áºÏÏû»¯ÔÓÖ¾2004£¬12(6)£º332-334.
ÎÂܰÌáʾ£ºÌÈÈôÄúÏëÁ˽â¸ü¶à¹ØÓÚÉϺ£À¶Ê®×ÖÄÔ¿ÆÒ½ÔºµÄ×îÐÂÐÅÏ¢£¬Äú¿ÉÒÔ²¦´òÎÒÔº½¡¿µÈÈÏß 021-64879999 »òÇëÔÚÏß×Éѯ¿Í·þ£¬ÎÒÃÇÌṩʵʱҽѶ¡¢¼²²¡×Éѯ¡¢×¨¼ÒÔ¤Ô¼µÈ·þÎñ¡£¿´²¡ÕÒר¼Ò£¬Ô¤Ô¼ÕÒ¿Í·þ£¬ÄÜΪÄúµÄ½¡¿µ±£¼Ý»¤º½ÊÇÎÒÃÇ×î´óµÄÈÙÐÒ£¬¸ÐлÄúµÄÖ§³ÖÓëÐÅÈΣ¡
×£°×ÒÂÌìʹÃǽÚÈÕ¿ìÀÖ£¬Ô¸ÄãÃÇÓÀÔ¶±»×ðÖØÓë×£¸££¡...¡¾Ïêϸ¡¿